GSK announced a $5 million Innovation Challenge Fund (ICF) for the advancement of collaborative research as part of its effort to develop bioelectronic medicines. The fund will support academic groups and small companies who want to develop solutions for GSK’s Bioelectronics Innovation Challenge. The new funding programme adds to GSK’s prior commitment of a $1 million award, announced in December 2013, for the team that first solves the Challenge. Funding will be awarded in two phases to qualified teams, ultimately leading to the selection of up to three teams being awarded up to $1.2 million each by mid-2015.